SEARCH

SEARCH BY CITATION

References

  • Cho, B.S., Yahng, S.A., Lee, S.E., Eom, K.S., Kim, Y.J., Kim, H.J., Lee, S., Min, C.K., Cho, S.G., Kim, D.W., Lee, J.W., Min, W.S. & Park, C.W. (2010) Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation, 90, 918926.
  • Erdbruegger, U., Woywodt, A., Kirsch, T., Haller, H. & Haubitz, M. (2006) Circulating endothelial cells as a prognostic marker in thrombotic microangiopathy. American Journal of Kidney Diseases, 48, 564570.
  • Karlin, L., Arnulf, B., Chevret, S., Ades, L., Robin, M., De Latour, R.P., Malphettes, M., Kabbara, N., Asli, B., Rocha, V., Fermand, J.P. & Socie, G. (2011) Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy. Bone Marrow Transplantation, 46, 250256.
  • Laskin, B.L., Goebel, J., Davies, S.M. & Jodele, S. (2011) Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood, 118, 14521462.